Role of Parecoxib Sodium for Postoperative Pain Management in Open Hepatectomy

Last updated: July 29, 2014
Sponsor: Peking Union Medical College Hospital
Overall Status: Trial Status Unknown

Phase

4

Condition

Hemangioma

Treatment

N/A

Clinical Study ID

NCT02204878
PUMCH-Liver-Dynastat
  • Ages 20-70
  • All Genders

Study Summary

To searching the role of parecoxib sodium for postoperative pain management in open hepatectomy

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age between 20-70 years old;

  • Hepatic hemangioma patients who will undergo laparotomy surgery: diameter of hepatichemangioma between 5-15cm, located in the right liver;

  • Child score 5-6;

  • BMI: 19-25;

  • ASA: Ⅰ ~ Ⅱ grade;

  • No comorbidities such as diabetes, hypertension, cardio renal or respiratorydysfunction, mental illness;

  • No known allergies;

  • No participation in other clinical trials within 2 months;

  • Have been informed consent.

  • Surgery-related: right subcostal incision, surgical time< 4 hours, hepatic pedicleocclusion time< 20 minutes, bleeding< 1000ml, no blood transfusions.

Exclusion

Exclusion Criteria:

  • History of chronic pain,long-term use of analgesic drugs or alcohol abuse;

  • Allergic to NSAIDs, opioids or sulfa drugs;

  • Coagulopathy or other hematological disorder;

  • Active peptic ulcer, gastrointestinal bleeding, inflammatory bowel disease;

  • Pregnant or lactating;

  • Mentally unstable to use PCA;

  • Preoperative pain caused by other disease;

  • Analgesic drugs or NSAIDs intake one week before surgery;

  • Preoperative systemic inflammatory response syndrome;

  • Preoperative chemotherapy or radiotherapy;

  • Preoperative or postoperative use of steroids;

  • Operative time> 4 hours, hepatic pedicle occlusion time> 20 minutes, blood loss> 1000ml, or intraoperative blood transfusion;

  • TBil> 34 umol/L、PT prolongation> 3S、ALB< 30 g/L、or Child score> 7 within 42 hoursafter surgery;

  • Bleeding、biliary fistula, intra-abdominal infections or other postoperativecomplications.

Study Design

Total Participants: 100
Study Start date:
July 01, 2014
Estimated Completion Date:

Connect with a study center

  • Peking union medical college hospital

    Beijing, Beijing 100032
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.